Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano Nivasha silver nanoparticle cream versus betamethasone for psoriasis
IRCT20220531055037N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of betamethasone in psoriasis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Psoriasis symptoms improvement and Time to symptom change. Started Jul 2022; status: completed.
02
Drugs
betamethasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on IRCT20220531055037N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220531055037N1.